Dan Polen - Polen Capital Management
Holding/activity history for BridgeBio Pharma Inc. (BBIO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 45,934 | 0.02 | Add 20.12% | <0.01 | $74.26 | $3,411,059 | SEC |
| 2025 Q4 | 38,241 | 0.01 | Add 5.74% | <0.01 | $76.49 | $2,925,054 | SEC |
| 2025 Q3 | 36,164 | 0.01 | Add 1.44% | <0.01 | $51.94 | $1,878,358 | SEC |
| 2025 Q2 | 35,649 | <0.01 | Buy | <0.01 | $43.18 | $1,539,324 | SEC |